Background. Haemophilus ducreyi (HD) and Treponema pallidum subspecies pertenue (TP) are major causative agents of cutaneous ulcer (CU) in the tropics. Azithromycin is recommended to treat sexually transmitted HD infections and has good in vitro activity against HD strains from both genital and skin ulcers. We investigated the efficacy of oral single-dose azithromycin on HD-CU.
Haemophilus ducreyi (HD) is commonly known as the causative agent of the genital ulcerative disease chancroid [1] . Recent research has also identified HD as the etiologic agent of cutaneous ulcer (CU) in travelers and residents coming from the South Pacific and Africa as a result of nonsexual transmission [2, 3] . Community-based studies conducted in Ghana, Papua New Guinea (PNG), Solomon Islands, and Vanuatu have confirmed that this bacterium is responsible for almost one-third of the cases of CU in rural environments of tropical countries; yaws infection, caused by Treponema pallidum subspecies pertenue (TP), leads to another third [4] [5] [6] [7] [8] , and an additional third of cases is caused by an as yet unknown organism(s) [4, 6, 8] .
Both yaws and HD skin ulcers affect mostly the limbs, of children aged 5-15 years, following a break or a wound in the skin and as a result of poor hygiene conditions [9] . Unlike yaws, HD-CUs appear to be restricted to the skin and, if left untreated, do not result in inflammatory lesions of the bones or cartilaginous tissues. HD-CU is diagnosed on the basis of leg ulcers with detectable HD-DNA by polymerase chain reaction (PCR). There is little doubt that HD is an etiologic agent because human inoculation experiments with HD on the upper arm have proven Koch's postulates, and the pathology report of HD-CU is identical to that of experimental infection [10] .
In 2012, the finding that a single oral dose of azithromycin was as effective as parenteral penicillin in the treatment of yaws [8] prompted the World Health Organization (WHO) to revisit the worldwide eradication of the disease. In an effort to eradicate yaws by 2020, WHO adopted a revised strategy, the Morges strategy [11] , employing mass azithromycin treatment of affected communities. Results of programs piloting the modern WHO strategy show a steep decrease in the prevalence of both yaws and HD-CU lesions [8] .
Azithromycin has good in vitro activity against HD genital ulcer strains [12, 13] , and several CU strains from patients infected in Samoa, Vanuatu, and PNG were macrolide sensitive with a similar susceptibility pattern as the genital ulcer strain 35000HP [14, 15] . In addition, several clinical studies presented cure rates of chancroid of >90% after treatment with azithromycin [16, 17] , and a single 1-g oral dose of azithromycin is one of the currently recommended antibiotics for the treatment of chancroid [18] . Therefore, azithromycin has the potential to be proven efficacious as a treatment for HD skin infection, which would have implications on the current guidelines to treat CU in the tropics and to eradicate yaws. WHO and the National Treatment Guidelines of PNG recommend azithromycin 30 mg/ kg (to a maximum of 2 g for adults) orally when yaws is serologically confirmed [11] . Ulcers with a negative syphilis serology, which are caused by HD and other pathogens, are typically treated with penicillin derivatives (ie, amoxicillin 500 mg 3 times daily for 5 days), chloramphenicol 500 mg 4 times daily for 7 days, or metronidazole 500 mg 3 times daily for 7 days. In common with recommendations to treat genital ulcer disease in resource-poor settings, it may be appropriate to devise "syndromic management" for CU in the tropics based on the use of azithromycin.
The primary objective of this study was to assess the efficacy of a single oral dose of azithromycin for ulcers with detectable HD-DNA by PCR.
METHODS

Participants and Study Setting
From October 2014 through May 2016, we assembled a prospective cohort of people from villages of Lihir Island, New Ireland Province, Papua New Guinea during biannual postmass treatment surveys of a yaws eradication program [8] .
We identified and assessed for eligibility all participants with skin ulcers. Persons with an atraumatic skin ulcer >1 cm in diameter that had a swab for PCR assessment collected were eligible for the study. We included only >1 cm ulcers to avoid small abrasions that could be only colonized but not caused by HD. We retrospectively classified patients according to PCR results into 3 groups: (1) subjects with HD ulcers (only HD-DNA was detected); (2) subjects with TP ulcers (only TP-DNA was detected); and (3) subjects with idiopathic ulcer (IU) (were negative in all tests). All participants were treated with directly observed single oral dose of azithromycin tablets (30 mg/kg, maximum 2 g), and were followed up at 14 days for repeated clinical assessment.
The protocol was approved by the National Medical Research Advisory Committee of the Papua New Guinea Ministry of Health (number 12.36). Children's parents or guardians provided oral informed consent to be screened and treated at that time.
Procedures
During each clinical survey, a physician carried out a structured assessment for skin ulcers of the face, arms, and legs of all the villagers. Information was recorded from every enrolled participant on a specifically designed data collection form. The clinician measured the location, size, shape, depth, and edges features of the ulcers. The investigators standardized objective criteria for the quantitative assessment of these characteristics. The location of the ulcer was recorded into a body chart. The size of the ulcer was recorded measuring the largest diameter of the ulcer in centimeters. The shape of the ulcer was assessed by measuring the wound major and minor axes, and a <20% difference between axes was used to confirm the impression obtained by visual inspection as to the circular shape of ulcers. The ulcer was considered to have elevated border if the entire border presented induration beneath the skin that extended immediately around the wound. An ulcer was defined as superficial when it presented partial thickness skin loss of the dermis presenting a shallow open ulcer with a pink would bed. An ulcer was defined as deep when it presented full thickness loss of the dermis or subcutaneous tissue (ie, deep crater with or without undermining of adjacent tissue). In addition, we assessed for signs of perilesional infection (ie, presence of erythema, warmth, tenderness, edema, or pain in the surrounding healthy skin), and necrosis (ie, devitalized tissue and purulent drainage or debris). A photograph and a dry sterile lesional swab of each of the skin ulcers were taken. All subjects received antibiotic treatment at the time of the survey in the presence of study personnel. In addition, basic wound care of the lesions was done.
Fourteen days after treatment with azithromycin, a physician and a local health worker located patients at their residence for assessment of clinical resolution. Photographic documentation of skin lesions was obtained at the 14-day follow-up visit for comparison over time. A consensus on treatment outcome was defined for each case as the one that the local health worker and one expert (C. G. B.) agreed upon after independent assessment. Cases for which there was no agreement were reviewed using photographs by a second expert (O. M.) for classification. Response to treatment was graded as healed, improved, or not improved. Two types of tissue repair where considered: diameter reduction of the ulcer and the appearance of granulation tissue (ie, deep pink or red with an irregular "berry-like" surface). An ulcer was graded as healed if (a) the ulcer was reduced by >50% in diameter or (b) the wound bed was filled with granulation tissue to the level of the surrounding skin or new epithelium (Figure 1 ). An ulcer was graded as improved or partially healed when (a) the ulcer reduced 1%-50% of its diameter or (b) >50% of the wound bed was covered with granulation tissue, with minimal necrotic tissue. Finally, we considered that an ulcer had not improved when there was (a) no diameter reduction and (b) nongranulating wound bed, signs/symptoms of infection, and/or necrotic tissue.
For ulcers noted as not improved, we collected a lesional swab at 14 days' follow-up and the patients were referred to the hospital for further assessment and management. Improved, but not completely healed ulcers were also resampled for PCR. Healed HD ulcers were not resampled.
Laboratory Tests
Specimens were sent to the University of Washington laboratory for testing of HD-DNA and TP-DNA. To detect HD-DNA, nucleic acids were purified on the MagNA Pure96 (Roche Diagnostics, Indianapolis, Indiana) with use of 200 μL of each resuspended specimen in the DNA and Viral NA Small Volume Kit (Roche Diagnostics). TaqMan real-time PCR targeting the 16S ribosomal RNA (rRNA) gene used previously published primers and probes. We followed the laboratory methods previously described for TP testing [4] . We judged a sample to be positive for yaws through molecular testing with 3 T. pallidum gene targets, including a pertenue-specific region to distinguish between treponemes that cause yaws (TP), or syphilis (T. pallidum subspecies pallidum), as described elsewhere [4] .
Definitions and Statistical Analyses
We calculated that a sample size of 139 participants with an HD-PCR-positive ulcer would be needed to assess treatment efficacy with a one-sided α of .05 and a power of 90%. We assumed healing rates of 90% at 14 days after treatment.
Ulcers were classified as due to HD when PCR tests identified HD-DNA alone, as TP when PCR test identified TP-DNA alone, and as IU when were negative (NEG) in both tests. Mixed infections with yaws and HD were not included in the analyses because we do not know which organism is causal or if they are both contributing to the infectious process.
We compared the clinical features of the participants with HD, TP, and NEG ulcers with Fisher exact test for categorical variables, and Mann-Whitney U tests for continuous variables. We reported odds ratios with 95% confidence intervals (CIs) from multinomial logistic regression to compare the clinical characteristics for ulcers caused by the different bacteria. The primary endpoint was healing rates of HD-CU at 14 days after treatment with azithromycin and the secondary endpoint was healing rates of TP-CU and IU. For the primary and secondary endpoints, we calculated proportions and a general linear model was used to analyze differences between groups (TP vs HD, and NEG vs HD). We did univariate and multivariate logistic regression models to investigate the association between HD-CU healing outcomes and baseline characteristics. All analyses were done with SPSS software version 24.
RESULTS
We analyzed 273 patients with skin ulcers who had conclusive PCR results and could be traced for a follow-up assessment 14 days after treatment. HD alone was identified in 131 (47.9%) ulcers, TP alone in 37 (13.5%), and 78 (28.5%) were negative for both pathogens. The remaining 27 (9.9%) ulcers had mixed infection with yaws and HD and were subsequently excluded from our primary analysis.
Demographic and Clinical Characteristics
The demographic and clinical characteristics upon presentation are summarized in Table 1 . Participants with HD-CU had a median age of 11 years (interquartile range, 9.0-13.0); 61 (46.6%) were male and 70 (53.4%) were female.
HD ulcers commonly presented as a localized deep lesion (59.5%), round in shape (57.3%) and with elevation of the ulcer edges 56.5%). The size of the ulcers ranged from 1 to 10 cm (median, 2.0 cm) and median duration before the diagnosis was 4.0 weeks. The base of the ulcer was rarely composed of necrotic tissue debris and/or a purulent exudate (5.4%). No complications such as perilesional infection, deep tissue abscess, or gangrene were noted in any case as a consequence of an ulcer.
HD-CU predominantly appeared on the lower limbs (97.7%) where it usually involved parts most susceptible to trauma, such as bony prominences, like the ankles. The ulcers were predominantly solitary, but spontaneous satellite lesions or ulcers related to additional trauma and self-inoculation through scratching were seen.
In comparison, TP ulcers presented significantly more often in boys (70.3% vs 46.6%; odds ratio [OR], 2.71), were more often deep (83.8% vs 59.5%; OR, 3.51) and round shaped (89.2% vs 57.3%; OR, 6.16), and had more often an elevated border (86.5% vs 56.5%; OR, 4.93). When we assessed the PCR-negative IU group, overall clinical characteristics were similar to the HD group (Table 1) .
Incidence of Primary and Secondary Endpoints
At 14 days' follow-up, 116 of 131 (88.5% [95% CI, 82.0%-92.9%]) patients with HD-CU had healed lesions. If we included the participants with improved ulcers, the healing rates increased to 94.7% (95% CI, 89.4%-97.4%) ( Table 2 ). For most of the patients, ulcers improved symptomatically within 2-4 days and substantial reepithelization occurred within the first week after the onset of therapy. Among 15 cases that were classified as not healed at 14 days, 6 had a swab collected for repeated PCR at the follow-up visit and all converted to HD negative.
In the TP group, the proportion of ulcers that had completely healed at 14 Table 3 shows epidemiologic and baseline clinical findings for cases with healed and not-healed HD-CU. Patients with not-healed ulcers presented with significantly larger median size ulcers (2.5 vs 2.0 cm; OR, 1.79 [95% CI, 1.20-2.68]) than patients with healed ulcers. Ulcer size remained significant in stepwise analysis (OR, 1.65 [95% CI, 1.12-2.41]). We did not find that duration of the episode before treatment or depth of the ulcer were significantly associated to not-healed ulcers.
Factors Associated to Not-Healed Ulcers
DISCUSSION
This study presents clinical data on the efficacy of azithromycin to treat H. ducreyi cutaneous ulcers (HD-CU). We found that almost 90% of HD-CU had reepithelialized at 14 days after treatment, and an additional 6% had improved. Furthermore, among the few not-healed HD ulcers with follow-up swabs, no ulcer had HD DNA detectable after treatment. Clinical data about the use of antibiotics to treat HD-CU are very limited. Several case reports have informed of resolution of the ulcers after treatment with penicillin, ceftriaxone, azithromycin, and cotrimoxazole [19] [20] [21] [22] . Non-yaws skin ulcers (with a negative syphilis test) in most resource-poor countries are normally treated empirically with penicillin derivatives. Based on drug susceptibility testing data of penicillin minimum inhibitory concentrations of 0.25 mg/L, most cutaneous HD strains would have responded well to β-lactams [19, 20] . However, recent reports have informed of CU strains that expressed β-lactamase [23] , similar to genital strains that are all resistant to penicillin. Azithromycin offers the advantage of single-dose oral therapy and we now provide definitive clinical data on the efficacy to treat HD-CU.
Our study describes in detail the clinical characteristics of HD ulcers, which were significantly different compared to PCR-defined TP ulcers in that TP presented more often a round shape with elevated edges, and affected a higher proportion of males. Furthermore, the TP group presented a higher proportion of bigger and deeper ulcers, although these differences were not statistically significant. Although TP ulcers presented slightly lower healing rates at 14 days than HD (78% vs 88%), when we included improved ulcers to the analysis, healing rates were equally high in both groups (97% vs 95%). This could be explained by the fact that larger TP ulcers need longer time to reach complete healing. Clinical presentation described here is consistent with that described in a former study in the same geographic area [4] , and corroborates that there are clinical differences between HD and yaws ulcers. However, clinical assessment of HD-CU alone is unlikely to be reliable enough to reach a diagnosis, and laboratory tests continue to be recommended.
The Lihir island area had undergone mass drug administration (MDA) with azithromycin for yaws in 2013. We have previously reported the continued incidence of HD ulcers in this rural population in PNG after MDA [8] . Now we have evidence that persistence of HD ulcers is not due to lack of response to azithromycin, but is likely due to the ubiquity of the organism in the environment. HD has been recently reported colonizing the skin of healthy subjects [24] ; if azithromycin does not reach the outer surface of skin, it may not interrupt colonization, and these sources may perpetuate the infection in the community.
Our study has several limitations. First, because of the observational nature of our study design, there was no untreated control group. Although a randomized trial design would have provided stronger evidence of effect, we can reasonably assume that the healing observed is attributable to treatment with an antibiotic agent. Second, the fact that HD has been found colonizing asymptomatic skin [24] implies that the positivity of PCR may not, in itself, be sufficient to make a definitive diagnosis of HD infection. However, the evidence from our study of high cure rates with antibiotic and HD converting to negative indicates that HD is causing the infection. In addition, we excluded small ulcers (<1 cm) that might actually be a scratch or mosquito bite which were colonized but not caused by HD.
In summary, azithromycin is a highly effective treatment against HD-caused cutaneous ulcers with clinical resolution at 14 days after treatment. Our results have implications for the treatment of individual patients and for the use of antibiotics in public health strategies to control CU in the tropics. Targeting HD-CU through yaws MDA campaigns should be considered together with hygiene promotion measures. Figure 1 Notes pallidum testing. We thank participants and the villagers of Lihir Island for their cooperation.
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